Ralimetinib dimesylate, CAS [[862507-23-1]]

Produktübersicht

• Artikelname: Ralimetinib dimesylate, CAS [[862507-23-1]]
• Artikelnummer: TGM-T6047
• Hersteller Artikelnummer: T6047
• Alternativnummer: TGM-T6047-1MLX10MM(INDMSO), TGM-T6047-1MG, TGM-T6047-5MG, TGM-T6047-10MG, TGM-T6047-25MG, TGM-T6047-50MG, TGM-T6047-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: LY2228820 dimesylate

Produktbeschreibung

Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.

Produkteigenschaften

• Molekulargewicht: 612.74
• Reinheit: 0.9938
• CAS Nummer: [862507-23-1]
• Formel: C24H29FN62CH4O3S
• Target-Kategorie: p38 MAPK|||Apoptosis|||Autophagy